Search Results for: OGT

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
TOR1AIP2 torsin 1A interacting protein 2
TP53 tumor protein p53
  • Activation of NOXA and translocation to mitochondria
  • Activation of PUMA and translocation to mitochondria
  • Pre-NOTCH Transcription and Translation
  • Oxidative Stress Induced Senescence
  • Formation of Senescence-Associated Heterochromatin Foci (SAHF)
  • Oncogene Induced Senescence
  • DNA Damage/Telomere Stress Induced Senescence
  • SUMOylation of transcription factors
  • Autodegradation of the E3 ubiquitin ligase COP1
  • Association of TriC/CCT with target proteins during biosynthesis
  • Pyroptosis
  • TP53 Regulates Metabolic Genes
  • Ub-specific processing proteases
  • Ovarian tumor domain proteases
  • Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks
  • Interleukin-4 and Interleukin-13 signaling
  • TP53 Regulates Transcription of DNA Repair Genes
  • TP53 Regulates Transcription of Genes Involved in Cytochrome C Release
  • TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain
  • TP53 Regulates Transcription of Caspase Activators and Caspases
  • TP53 Regulates Transcription of Death Receptors and Ligands
  • TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
  • TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain
  • TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest
  • Regulation of TP53 Expression
  • Regulation of TP53 Activity through Phosphorylation
  • Regulation of TP53 Degradation
  • Regulation of TP53 Activity through Acetylation
  • Regulation of TP53 Activity through Association with Co-factors
  • Regulation of TP53 Activity through Methylation
  • PI5P Regulates TP53 Acetylation
  • G2/M DNA damage checkpoint
  • G2/M Checkpoints
  • Stabilization of p53
  • Transcriptional activation of cell cycle inhibitor p21
  • The role of GTSE1 in G2/M progression after G2 checkpoint
  • Transcriptional Regulation by VENTX
  • RUNX3 regulates CDKN1A transcription
  • Regulation of PTEN gene transcription
  • Regulation of PTEN gene transcription
  • Loss of function of TP53 in cancer due to loss of tetramerization ability
  • Signaling by ALK fusions and activated point mutants
  • Regulation of NF-kappa B signaling
  • Zygotic genome activation (ZGA)
  • Factors involved in megakaryocyte development and platelet production
  • PKR-mediated signaling
  • Acetylsalicylic acid
  • Zinc
  • Triethyl phosphate
  • AZD 3355
  • 1-(9-ethyl-9H-carbazol-3-yl)-N-methylmethanamine
  • Zinc acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form
  • Chronic myeloid leukemia (CML)
  • Breast cancer
  • Non-small cell lung cancer
  • Gastric cancer
  • Adult T-cell leukemia
  • Choriocarcinoma
  • Esophageal cancer
  • Glioma
  • Pancreatic cancer
  • Vulvar cancer
  • Multiple myeloma
  • Choroid plexus papilloma
  • Ovarian cancer
  • Hepatocellular carcinoma
  • Squamous cell carcinoma
  • Endometrial Cancer
  • Penile cancer
  • Cancer of the anal canal
  • Hairy-cell leukemia
  • Oral cancer
  • Adrenal carcinoma
  • Malignant melanoma
  • Burkitt lymphoma
  • Thyroid cancer
  • Basal cell carcinoma
  • Small cell lung cancer
  • Gallbladder cancer
  • Bladder cancer
  • Laryngeal cancer
  • Kaposi's sarcoma
  • Cholangiocarcinoma
  • Chronic lymphocytic leukemia (CLL)
  • Li-Fraumeni syndrome, including: Classic Li-Fraumeni syndrome (LFS); LFS-like syndrome (LFSL)
  • Malignant pleural mesothelioma
  • Osteosarcoma
  • Colorectal cancer
TPP1 tripeptidyl peptidase 1
  • XBP1(S) activates chaperone genes
  • Progressive myoclonic epilepsy (PME), including: Lafora disease (LBD); Unverricht-Lundborg disease (ULD); Neuronal ceroid lipofuscinoses (NCL); Type I sialidosis; Action myoclonus-renal failure syndrome (AMRF); Type III Gaucher disease (GD)
  • Neuronal ceroid lipofuscinosis, including: Infantile Neuronal Ceroid Lipofuscinosis (INCL)/ Santavuori-Haltia Disease (CLN1); Late-Infantile Neuronal Ceroid Lipofuscinosis (LINCL)/ Jansky-Bielschowsky Disease (CLN2); Juvenile Neuronal Ceroid Lipofuscinosis (JNCL)/Batten Disease/ Spielmeyer-Vogt Disease (CLN3); Adult Neuronal Ceroid Lipofuscinosis (ANCL)/ Kufs Disease (CLN4); LINCL variant (CLN5, CLN6, CLN7, CLN8); Batten Disease variant (CLN9); Congenital NCL (CLN10)
TRAF4 TNF receptor associated factor 4
TRAF7 TNF receptor associated factor 7
  • Antigen processing: Ubiquitination & Proteasome degradation
TRAK1 trafficking kinesin protein 1
  • Signaling by BRAF and RAF1 fusions
  • RHOT2 GTPase cycle
  • RHOT1 GTPase cycle
TRAK2 trafficking kinesin protein 2
  • RHOT2 GTPase cycle
  • RHOT1 GTPase cycle
TRIM11 tripartite motif containing 11
  • Antigen processing: Ubiquitination & Proteasome degradation
TRIM27 tripartite motif containing 27
  • SUMOylation of ubiquitinylation proteins
  • Regulation of PTEN stability and activity
  • Suppression of apoptosis
TRIM28 tripartite motif containing 28
  • Generic Transcription Pathway
  • SUMOylation of transcription cofactors
  • HCMV Early Events
  • Regulation of endogenous retroelements by KRAB-ZFP proteins
  • Regulation of endogenous retroelements by KRAB-ZFP proteins
TRIP12 thyroid hormone receptor interactor 12
  • Antigen processing: Ubiquitination & Proteasome degradation
TRIT1 tRNA isopentenyltransferase 1
  • tRNA modification in the nucleus and cytosol
  • tRNA modification in the mitochondrion
TRMT10C tRNA methyltransferase 10C, mitochondrial RNase P subunit
  • tRNA processing in the mitochondrion
  • tRNA modification in the mitochondrion
  • rRNA processing in the mitochondrion
TRMT5 tRNA methyltransferase 5
  • Synthesis of wybutosine at G37 of tRNA(Phe)
TRMT6 tRNA methyltransferase 6 non-catalytic subunit
  • tRNA modification in the nucleus and cytosol
TSG101 tumor susceptibility 101
  • Budding and maturation of HIV virion
  • Membrane binding and targetting of GAG proteins
  • Endosomal Sorting Complex Required For Transport (ESCRT)
  • HCMV Late Events
  • Late endosomal microautophagy
TSPYL1 TSPY like 1
TTC31 tetratricopeptide repeat domain 31
TTC4 tetratricopeptide repeat domain 4
TUBA1A tubulin alpha 1a
  • Translocation of SLC2A4 (GLUT4) to the plasma membrane
  • Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane
  • Gap junction assembly
  • MHC class II antigen presentation
  • Separation of Sister Chromatids
  • Resolution of Sister Chromatid Cohesion
  • Regulation of PLK1 Activity at G2/M Transition
  • HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand
  • Loss of Nlp from mitotic centrosomes
  • Recruitment of mitotic centrosome proteins and complexes
  • Loss of proteins required for interphase microtubule organization from the centrosome
  • Recruitment of NuMA to mitotic centrosomes
  • Prefoldin mediated transfer of substrate to CCT/TriC
  • Formation of tubulin folding intermediates by CCT/TriC
  • Post-chaperonin tubulin folding pathway
  • Recycling pathway of L1
  • Recycling pathway of L1
  • Hedgehog 'off' state
  • Anchoring of the basal body to the plasma membrane
  • Cargo trafficking to the periciliary membrane
  • Intraflagellar transport
  • RHO GTPases activate IQGAPs
  • RHO GTPases Activate Formins
  • COPI-mediated anterograde transport
  • COPI-dependent Golgi-to-ER retrograde traffic
  • COPI-independent Golgi-to-ER retrograde traffic
  • Mitotic Prometaphase
  • The role of GTSE1 in G2/M progression after G2 checkpoint
  • AURKA Activation by TPX2
  • Carboxyterminal post-translational modifications of tubulin
  • Carboxyterminal post-translational modifications of tubulin
  • HCMV Early Events
  • Assembly and cell surface presentation of NMDA receptors
  • Activation of AMPK downstream of NMDARs
  • Aggrephagy
  • Aggrephagy
  • EML4 and NUDC in mitotic spindle formation
  • Sealing of the nuclear envelope (NE) by ESCRT-III
  • Kinesins
  • PKR-mediated signaling
  • Albendazole
  • Vinblastine
  • Mebendazole
  • Epothilone D
  • Patupilone
  • CYT997
  • 2-MERCAPTO-N-[1,2,3,10-TETRAMETHOXY-9-OXO-5,6,7,9-TETRAHYDRO-BENZO[A]HEPTALEN-7-YL]ACETAMIDE
  • Artenimol
  • Phenethyl Isothiocyanate
  • Colchiceine
  • Lissencephaly (LIS); Miller-Dieker syndrome (MDLS)

Page 32 out of 36 pages